Role of inflammatory pathways, blood mononuclear cells, and gut-derived bacterial products in alcohol dependence.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biological Psychiatry

• Publication date

  2014-11-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.biopsych.2014.02.003PMID 24629538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

  2013cited by this paper
• Is anxious-depression an inflammatory state?

  2013cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects.

  2012influential reference
• The Loss of Metabolic Control on Alcohol Drinking in Heavy Drinking Alcohol-Dependent Subjects

  2012cited by this paper
• Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome.

  2011cited by this paper
• Enteric dysbiosis associated with a mouse model of alcoholic liver disease

  2011cited by this paper
• Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders.

  2011cited by this paper
• Current Views of Toll-Like Receptor Signaling Pathways

  2010cited by this paper
• The inflammasomes.

  2010cited by this paper
• Distinct effects of protracted withdrawal on affect, craving, selective attention and executive functions among alcohol-dependent patients.

  2010cited by this paper
• Pattern recognition receptors and inflammation.

  2010cited by this paper
• JNK pathway is required for TNCB-induced IL-18 expression in murine keratinocytes.

  2010cited by this paper
• The bacterial cell envelope.

  2010cited by this paper
• Pivotal Role of TLR4 Receptors in Alcohol-Induced Neuroinflammation and Brain Damage

  2010cited by this paper
• Alcoholism: a systems approach from molecular physiology to addictive behavior.

  2009cited by this paper
• Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.

  2009cited by this paper
• Mechanisms of neurodegeneration and regeneration in alcoholism.

  2009cited by this paper
• Evidence that chronic alcohol exposure promotes intestinal oxidative stress, intestinal hyperpermeability and endotoxemia prior to development of alcoholic steatohepatitis in rats.

  2009cited by this paper
• TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β

  2008cited by this paper
• Absolute and relative stability of alexithymia in alcoholic inpatients undergoing alcohol withdrawal: relationship to depression and anxiety.

  2008cited by this paper
• Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

  2008cited by this paper
• Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study.

  2008cited by this paper
• Increased MCP-1 and microglia in various regions of the human alcoholic brain.

  2008cited by this paper
• Signaling to NF-?B by Toll-like receptors

  2007cited by this paper
• Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling.

  2007cited by this paper
• Depressive disorders and immunity: 20 years of progress and discovery.

  2007cited by this paper
• Signaling to NF-kappaB by Toll-like receptors.

  2007cited by this paper
• Alcohol in Europe – Public Health Perspective: Report summary

  2006cited by this paper
• Pathogen recognition and innate immunity.

  2006cited by this paper
• TLR signaling

  2006cited by this paper
• Cytokines and alcohol.

  2006cited by this paper
• Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor

  2006cited by this paper
• Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome.

  2004cited by this paper
• Costunolide inhibits interleukin-1beta expression by down-regulation of AP-1 and MAPK activity in LPS-stimulated RAW 264.7 cells.

  2004cited by this paper
• Toll‐like receptor 2‐dependent bacterial sensing does not occur via peptidoglycan recognition

  2004influential reference
• Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection*

  2003influential reference
• LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF

  2003cited by this paper
• Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans.

  2003cited by this paper
• ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding.

  2002cited by this paper
• Chronic Ethanol Increases Lipopolysaccharide-stimulated Egr-1 Expression in RAW 264.7 Macrophages

  2002cited by this paper
• Multiple control of interleukin‐8 gene expression

  2002cited by this paper
• LPS induction of gene expression in human monocytes.

  2001influential reference
• Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis.

  2000cited by this paper
• Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease.

  2000cited by this paper
• A French Translation of the Obsessive-Compulsive Drinking Scale for Craving in Alcohol-Dependent Patients: A Validation Study in Belgium, France, and Switzerland

  2000cited by this paper
• Major depression and activation of the inflammatory response system.

  1999cited by this paper
• MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4

  1999cited by this paper
• The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior.

  1995cited by this paper
• CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein.

  1990cited by this paper
• Increased tumor necrosis factor production by monocytes in alcoholic hepatitis

  1989cited by this paper
• Jejunal microflora in patients with chronic alcohol abuse.

  1984cited by this paper
• Comparison of two techniques to obtain retrospective reports of drinking behavior from alcohol abusers.

  1982cited by this paper

• White matter microstructure alterations from alcohol use disorder persist into early abstinence

  2026cites this paper
• Chronic stress, gut dysbiosis, and cholesterol metabolism: Implications for Alzheimer's disease.

  2026cites this paper
• Sex differences in inflammatory mechanisms related to alcohol use disorder and depression.

  2025cites this paper
• Microbiome and gut-liver interactions: From mechanisms to therapies

  2025cites this paper
• The effect of alcohol withdrawal therapy on gut microbiota in alcohol use disorder and its link to inflammation and craving

  2025influential citation
• Targeting gut health: Probiotics as promising therapeutics in alcohol-related liver disease management

  2025cites this paper
• Alcohol Intake-Induced Aggravation of Chronic Prostatitis/Chronic Pelvic Pain Syndrome is Associated with Reduced Gut Microbiota-Driven Short-Chain Fatty Acid Propionate and Butyrate.

  2025cites this paper
• Inflammatory endotoxin challenge in individuals with alcohol use disorder and controls.

  2025cites this paper
• Microglia promote neurodegeneration and hyperkatifeia during withdrawal and prolonged abstinence from binge alcohol

  2025cites this paper
• Alcohol Use Disorder and the Gut–Brain Axis: A Narrative Review of the Role of Gut Microbiota and Implications for Treatment

  2025cites this paper
• The Bidirectional Interplay Between Substances of Abuse and Gut Microbiome Homeostasis

  2025cites this paper
• Neuroglia in substance use disorders.

  2025cites this paper
• Microglia Promote Neurodegeneration and Hyperkatifeia during Withdrawal and Abstinence from Binge Alcohol

  2025cites this paper
• Gut Microbiome-Liver-Brain axis in Alcohol Use Disorder. The role of gut dysbiosis and stress in alcohol-related cognitive impairment progression: possible therapeutic approaches

  2025cites this paper
• Effect of the GLP‐1 receptor agonist exenatide on pro‐inflammatory and metabolic biomarkers in individuals with alcohol use disorder: Post hoc results from a randomized, double‐blinded, placebo‐controlled clinical trial

  2025cites this paper
• The Link Between Alcohol Consumption and Kidney Injury.

  2025cites this paper
• Neurotransmitters, factors of neuroimmune inflammation and endocrine regulation in alcohol dependence

  2025cites this paper
• Immunological mechanisms and emerging therapeutic targets in alcohol-associated liver disease

  2025cites this paper
• Longitudinal changes in sleep quality in male patients with alcohol dependence receiving far-infrared ray therapy: associations with alterations in circulating pro-inflammatory cytokines

  2025cites this paper
• Effect of inulin supplementation on fecal and blood metabolome in alcohol use disorder patients: A randomised, controlled dietary intervention.

  2025cites this paper
• Alcoholic brain injury is a modifiable risk factor: natural active substance intervention promises to improve alcohol-induced cognitive impairment

  2025cites this paper
• The Impact of Alcohol on the Gut Microbiota: A literature review

  2025cites this paper
• From bugs to behavior: targeting the gut-brain interface for addiction therapeutics

  2025cites this paper
• Liver as a key organ for systemic antimicrobial defense

  2025cites this paper
• Circulating Immune and Endocrine Markers in Currently Drinking and Abstinent Individuals With Alcohol Use Disorder and Controls

  2025cites this paper
• TNFR1 and TNFR2 levels in patients with severe alcohol use disorder undergoing withdrawal and their relationship with delirium tremens.

  2025cites this paper
• Chronic binge drinking-induced susceptibility to colonic inflammation is microbiome-dependent

  2024cites this paper
• The gut-brain axis in individuals with alcohol use disorder: An exploratory study of associations among clinical symptoms, brain morphometry, and the gut microbiome.

  2024cites this paper
• Linking alcohol use to Alzheimer’s disease: Interactions with aging and APOE along immune pathways

  2024cites this paper
• Involvement of the gut microbiome-brain axis in alcohol use disorder.

  2024cites this paper
• Rifaximin treatment in patients with severe alcoholic hepatitis: A multicenter, randomized controlled, open-label, pilot trial.

  2024cites this paper
• Association between alcohol consumption levels and pelvic inflammatory disease: Findings from the NHANES 2013–2020

  2024cites this paper
• Standard rodent diets differentially impact alcohol consumption and preference and gut microbiome diversity

  2024cites this paper
• Standard rodent diets differentially impact alcohol consumption, preference, and gut microbiome diversity

  2024cites this paper
• Quel rôle joue le microbiote intestinal dans le trouble de l’usage d’alcool ?

  2024cites this paper
• The gut-liver axis in fatty liver disease: role played by natural products.

  2024cites this paper
• Molecular mechanisms involved in alcohol craving, IRF3, and endoplasmic reticulum stress: a multi-omics study

  2024cites this paper
• The gut microbiome in alcohol use disorder and alcohol-associated liver disease: A systematic review of clinical studies.

  2024cites this paper
• Major depressive disorder: hypothesis, mechanism, prevention and treatment

  2024cites this paper
• Examining the moderating role of cannabis use on the relationship between alcohol consumption and inflammation in individuals with alcohol use disorder

  2024cites this paper
• Microbiome interactions with different risk factors in development of myocardial infarction.

  2024cites this paper
• Elevations in interleukin-8 levels in individuals with alcohol use disorder and clinical insomnia symptoms.

  2024cites this paper
• Role of the Microbiome and the Gut-Brain Axis in Alcohol Use Disorder: Potential Implication for Treatment Development.

  2024cites this paper
• The Interplay Between Gut Microbiota and Central Nervous System.

  2023cites this paper
• One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease

  2023cites this paper
• Alcohol use disorder (AUD) is associated with enhanced sensitivity to cellular lipopolysaccharide challenge.

  2023cites this paper
• Novel paradigms for the gut–brain axis during alcohol withdrawal, withdrawal-associated depression, and craving in patients with alcohol use disorder

  2023cites this paper
• Molecular mechanisms of alcohol's effects on the human body: A review and update

  2023cites this paper
• Binge drinking episode causes acute, specific alterations in systemic and hepatic inflammation‐related markers

  2023cites this paper
• Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk

  2023cites this paper
• Ethanol Induces Neuroinflammation in a Chronic Plus Binge Mouse Model of Alcohol Use Disorder via TLR4 and MyD88-Dependent Signaling

  2023cites this paper
• Gut microbiota influence frailty syndrome in older adults: mechanisms and therapeutic strategies

  2023cites this paper
• In vitro, in vivo, and in silico analysis of synbiotics as preventive interventions for lipid metabolism in ethanol-induced adipose tissue injury

  2023cites this paper
• Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans

  2023influential citation
• Possible role of nutrition in the prevention of inflammatory bowel disease-related colorectal cancer: A focus on human studies.

  2023cites this paper
• Distinct dynamic behavioural response to social exclusion in male patients with a history of alcohol dependence

  2023cites this paper
• adgrl3.1-deficient zebrafish show noradrenaline-mediated externalizing behaviors, and altered expression of externalizing disorder-candidate genes, suggesting functional targets for treatment

  2023cites this paper
• The Microbiome-Gut-Brain axis regulates social cognition & craving in young binge drinkers

  2023cites this paper
• The association between oral and gut microbiota in male patients with alcohol dependence

  2023cites this paper
• Imaging the brain’s immune response to alcohol with [^11C]PBR28 TSPO Positron Emission Tomography

  2023cites this paper
• Alterations and correlations of gut microbiota, fecal, and serum metabolome characteristics in a rat model of alcohol use disorder

  2023cites this paper
• Alcohol Use Disorder and the Gut Microbiome

  2023cites this paper
• Marijuana use and DNA methylation-based biological age in young adults

  2022cites this paper
• Different brain oxidative and neuroinflammation status in rats during prolonged abstinence depending on their ethanol relapse-like drinking behavior: Effects of ethanol reintroduction.

  2022cites this paper
• Detrimental Effects of Alcohol-Induced Inflammation on Brain Health: From Neurogenesis to Neurodegeneration

  2022cites this paper
• NLRP3 deficiency decreases alcohol intake controlling anxiety-like behavior via modification of glutamatergic transmission in corticostriatal circuits

  2022cites this paper
• Attenuation of the levels of pro-inflammatory cytokines prevents depressive-like behavior during ethanol withdrawal in mice.

  2022cites this paper
• Alcohol use disorder, neuroinflammation, and intake of dietary fibers: a new approach for treatment

  2022cites this paper
• The Microbiota–Gut–Brain Axis in Psychiatric Disorders

  2022cites this paper
• Illustration of Gut–Thyroid Axis in Alcohol Use Disorder: Interplay of Gut Dysfunction, Pro-Inflammatory Responses, and Thyroid Function

  2022cites this paper
• The diversity of the intestinal microbiota in patients with alcohol use disorder and its relationship to alcohol consumption and cognition

  2022cites this paper
• Gut-Brain Axis: Probiotic Interactions and Implications for Human Mental Health

  2022cites this paper
• Inflammatory cytokines and alcohol use disorder: systematic review and meta-analysis

  2022cites this paper
• An exploratory study of pro-inflammatory cytokines in individuals with alcohol use disorder: MCP-1 and IL-8 associated with alcohol consumption, sleep quality, anxiety, depression, and liver biomarkers

  2022cites this paper
• Gut microbiota dysbiosis: The potential mechanisms by which alcohol disrupts gut and brain functions

  2022cites this paper
• Liver alterations are not improved by inulin supplementation in alcohol use disorder patients during alcohol withdrawal: A pilot randomized, double-blind, placebo-controlled study

  2022cites this paper
• Chronic systemic low-grade inflammation and modern lifestyle: the dark role of gut microbiota on related diseases with a focus on pandemic COVID-19.

  2022cites this paper
• Stress- and drug-induced neuroimmune signaling as a therapeutic target for comorbid anxiety and substance use disorders.

  2022cites this paper
• Nutrition and addiction - are they linked in de-addictive process? A review

  2022cites this paper
• The Significance of Toll-Like Receptors in the Neuroimmunologic Background of Alcohol Dependence

  2022cites this paper
• Cytokine level in patients with mood disorder, alcohol use disorder and their comorbidity

  2022cites this paper
• Gut microbiota and voluntary alcohol consumption

  2022cites this paper
• Cyclic Nucleotide Phosphodiesterases in Alcohol Use Disorders: Involving Gut Microbiota

  2022cites this paper
• Increased Toll‐like Receptor‐MyD88‐NFκB‐Proinflammatory neuroimmune signaling in the orbitofrontal cortex of humans with alcohol use disorder

  2021cites this paper
• Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia

  2021cites this paper
• Reduced alcohol use in patients prescribed pioglitazone.

  2021cites this paper
• The Immune System through the Lens of Alcohol Intake and Gut Microbiota

  2021cites this paper
• Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease

  2021cites this paper
• TLR4 Deficiency Affects the Microbiome and Reduces Intestinal Dysfunctions and Inflammation in Chronic Alcohol-Fed Mice

  2021cites this paper
• The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?

  2021cites this paper
• The Impact of Alcohol-Induced Dysbiosis on Diseases and Disorders of the Central Nervous System

  2021cites this paper
• The Microbiome–Gut–Brain Axis, a Potential Therapeutic Target for Substance-Related Disorders

  2021cites this paper
• Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms

  2021cites this paper
• Innate gut microbiota predisposes to high alcohol consumption

  2021cites this paper
• The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD.

  2021cites this paper
• Gut-derived systemic inflammation as a driver of depression in chronic liver disease.

  2021cites this paper
• Chemokines, cytokines and substance use disorders.

  2021cites this paper
• Restoring an adequate dietary fiber intake by inulin supplementation: a pilot study showing an impact on gut microbiota and sociability in alcohol use disorder patients

  2021influential citation
• Probiotics-Based Treatment as an Integral Approach for Alcohol Use Disorder in Alcoholic Liver Disease

  2021cites this paper
• Clinical Neuroscience of Addiction: What Clinical Psychologists Need to Know and Why.

  2021cites this paper